![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | (2006.01) |
C07K 16/28 | (2013.01) | ||
G01N 33/57492 | (2013.01) | ||
A61K 47/6809 | (2017.08) | ||
A61K 47/6849 | (2017.08) | ||
A61K 47/6869 | (2017.08) | ||
A61P 35/00 | (2018.01) | ||
A61P 43/00 | (2018.01) |
(11) | Number of the document | 3636279 |
(13) | Kind of document | T |
(96) | European patent application number | 19192583.3 |
Date of filing the European patent application | 2012-03-30 | |
(97) | Date of publication of the European application | 2020-04-15 |
(45) | Date of publication and mention of the grant of the patent | 2023-09-13 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
201161471007 P | 2011-04-01 | US |
(72) |
Carrigan, Christina , US
Whiteman, Kathleen R. , US
Payne, Gillian , US
Ladd, Sharron , US
|
(73) |
ImmunoGen, Inc. ,
830 Winter Street, Waltham, MA 02451,
US
|
(54) | METHODS FOR INCREASING EFFICACY OF FOLR1 CANCER THERAPY |
METHODS FOR INCREASING EFFICACY OF FOLR1 CANCER THERAPY |